SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology (MU) shares are experiencing explosive upward momentum, driven by an analyst upgrade that more than tripled its price target, fueling community discussion around AI's transformative impact on the memory chip sector and its rapid ascent to a $1 trillion market cap.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Space stock Redwire Corp (RDW) is surging on significant community excitement and a potential boost from SpaceX's recent Starship test flight, with many discussing the sector's strong performance and RDW's potential for further gains.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus is experiencing extreme volatility and rapid price increases, with traders excitedly discussing short squeezes and parabolic moves, fueled by speculation surrounding the upcoming SpaceX IPO and a recent insider purchase by astronaut Chris Hadfield.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is trending due to intense community debate around its parabolic rise, with many calling it a bubble reminiscent of the dot-com era, while others are aggressively playing the upside, creating significant volatility and discussion around potential catalysts and market timing.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Traders are closely watching SOXS as the semiconductor sector experiences extreme volatility, with many discussing potential entry points and the impact of Micron Technology's (MU) significant price swings. The community is debating whether the current AI-driven rally in chips is sustainable or nearing a peak, leading to discussions about the risks and rewards of inverse leveraged ETFs like SOXS.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler's recent earnings report revealed stronger-than-expected revenue and EPS, alongside a solid ARR growth and record profitability. However, the forward guidance for Q4 revenue came in slightly below analyst estimates, and a cut to free cash flow margin guidance alongside increased capex sparked investor concern about future growth deceleration, leading to significant after-hours selling pressure despite the strong quarterly performance.

CPS Technologies Corp. engages in the provision of advanced material solutions to the transportation, automotive, energy, computing or Internet, telecommunications, aerospace, defense, and oil and gas end markets. The firm focuses on the design, manufacture, and sale of custom metal matrix composite components. It also assembles housings and packages for hybrid circuit. The company was founded in 1984 and is headquartered in Norton, MA.

CPS Technologies Corporation

CPSH is trending due to significant retail interest driven by speculation of it being a SpaceX supplier and its role in the burgeoning space economy, amplified by its inclusion in the NASA ETF and recent contract wins in advanced materials.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Amidst soaring conversations about the potential for a market top and parabolic gains, $SOXL is buzzing as traders debate whether the semiconductor sector's rapid ascent is sustainable or a bubble poised for a sharp correction, with many eyeing potential short opportunities.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming (CRSR) is surging on strong Q4 earnings, record gross margins, and an $84M increase in adjusted EBITDA, alongside a new $50M share repurchase program, fueling community excitement about a potential turnaround and short squeeze.

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, and Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.

Lifevantage Corporation

Lifevantage Corp. is experiencing significant buzz and speculation around a potential short squeeze, driven by extremely high short interest, a low float, and active share repurchase programs. Community discussions highlight the unusual borrowing costs and a rare combination of factors that could fuel a substantial price increase.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace...

GRCE Stock On Track For Worst Week In 5.5 Years —  What’s Driving The Selloff?

Equity

Earlier this week, the FDA refused to approve Grace Therapeutics’s experimental drug for the treatment of a severe form of acute brain injury.


GRCE Stock Plunges 45% After FDA Rejects Brain Injury Drug — Company Says Concerns Are Fixable

Grace Therapeutics was seeking FDA approval for GTx-104 in the treatment of patients with aneurysmal subarachnoid hemorrhage. 


GRCE Stock In Spotlight Ahead Of FDA Verdict On Brain Bleed Drug This Week 

The FDA set a Prescription Drug User Fee Act target action date of April 23 to rule on GTx-104, a potential treatment for patients with aneurysmal subarachnoid hemorrhage.

Short Interest in Grace Therapeutics, Inc. (NASDAQ:GRCE) Grows By 300.8%

Grace Therapeutics, Inc. (NASDAQ:GRCE - Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling...

Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update

Grace Therapeutics, Inc. (NASDAQ:GRCE - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling...

Grace Therapeutics, Inc. (NASDAQ:GRCE - Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 13th, there was short interest totaling...

Grace Therapeutics (NASDAQ:GRCE) Announces Earnings Results

Grace Therapeutics (NASDAQ:GRCE - Get Free Report) posted its earnings results on Thursday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus...

Grace Therapeutics (GRCE) Expected to Announce Quarterly Earnings on Thursday

Grace Therapeutics (NASDAQ:GRCE) will be releasing its Q3 2026 earnings before the market opens on Thursday, February 12. (View Earnings Report at...

Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Up 34.6% in January

Grace Therapeutics, Inc. (NASDAQ:GRCE - Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totaling...

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.23	--	--	N/A
Q3 '25	-$0.28	-$0.14	50.00%	BEAT
Q2 '25	-$0.25	-$0.06	76.11%	BEAT
Q1 '25	-$0.22	-$0.21	4.55%	BEAT
Q4 '24	-$0.28	$0.11	139.64%	BEAT

GRCE
Grace Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Compact View

Latest GRCE News

GRCEGrace Therapeutics Inc.